Encompass Health Co. (NYSE:EHC) Given Consensus Recommendation of “Buy” by Brokerages

Encompass Health Co. (NYSE:EHC) has earned a consensus recommendation of “Buy” from the eleven brokerages that are presently covering the stock, MarketBeat reports. Nine analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $107.67.

EHC has been the topic of several research reports. KeyCorp increased their price target on shares of Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Monday, February 10th. Truist Financial reaffirmed a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. StockNews.com raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday. Barclays raised their target price on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, February 7th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $110.00 target price on shares of Encompass Health in a report on Tuesday, February 11th.

Insider Transactions at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 2.10% of the company’s stock.

Institutional Trading of Encompass Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in EHC. CIBC Asset Management Inc grew its holdings in shares of Encompass Health by 3.5% during the 3rd quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock worth $286,000 after purchasing an additional 100 shares during the period. Miracle Mile Advisors LLC grew its holdings in shares of Encompass Health by 3.0% during the 4th quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock worth $354,000 after purchasing an additional 112 shares during the period. US Bancorp DE grew its holdings in shares of Encompass Health by 9.6% during the 4th quarter. US Bancorp DE now owns 1,380 shares of the company’s stock worth $127,000 after purchasing an additional 121 shares during the period. Signaturefd LLC grew its holdings in shares of Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company’s stock worth $65,000 after purchasing an additional 125 shares during the period. Finally, CBIZ Investment Advisory Services LLC grew its holdings in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after purchasing an additional 127 shares during the period. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Trading Up 1.4 %

NYSE EHC opened at $102.31 on Wednesday. The stock has a market capitalization of $10.31 billion, a P/E ratio of 22.94, a PEG ratio of 1.18 and a beta of 0.90. Encompass Health has a 12 month low of $73.02 and a 12 month high of $104.55. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The firm’s 50-day moving average is $95.97 and its two-hundred day moving average is $95.68.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 18.06%. On average, sell-side analysts anticipate that Encompass Health will post 4.76 earnings per share for the current year.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.